植物固醇血症:地中海饮食引起的矛盾性高胆固醇血症病例

IF 3.6 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Rahul Rege MD, Carol Kirkpatrick PhD, Alexandria Wolz RD, Eugenia Gianos MD, Saman Suleman BS
{"title":"植物固醇血症:地中海饮食引起的矛盾性高胆固醇血症病例","authors":"Rahul Rege MD,&nbsp;Carol Kirkpatrick PhD,&nbsp;Alexandria Wolz RD,&nbsp;Eugenia Gianos MD,&nbsp;Saman Suleman BS","doi":"10.1016/j.jacl.2025.04.047","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Synopsis</h3><div>Phytosterolemia is a rare autosomal recessive lipid disorder caused by variants of the sterol efflux transporter genes ABCG5 and ABCG8 leading to increased intestinal absorption and decreased hepatic elimination of plant sterols. Patients may be misdiagnosed with heterozygous familial hypercholesterolemia. Additionally, they may present with atypical responses to nutrition interventions recommended for atherosclerotic cardiovascular disease (ASCVD) prevention.</div></div><div><h3>Objective/Purpose</h3><div>To describe the clinical pathway of a patient who experienced increased total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels after adopting a Mediterranean dietary pattern and outline diagnostic testing and management strategies for a rare lipid disorder.</div></div><div><h3>Methods</h3><div>We present a case report.</div></div><div><h3>Results</h3><div>HT is a 54-year-old post-menopausal woman who presented to preventive cardiology clinic for consultation for hypercholesterolemia. Baseline TC was 256 mg/dL and LDL-C was 148 mg/dL. HT was physically active with no history of smoking. Family history was negative for premature ASCVD. On physical exam, she had a BMI of 22.49 kg/m<sup>2</sup>, a normal cardiovascular exam, and no xanthomas were noted.</div><div>HT's 10-year ASCVD risk score indicated low-risk (1.1%). HT was encouraged to follow the Mediterranean dietary pattern (MedDiet) to address her elevated LDL-C levels. HT demonstrated good adherence and increased her intake of whole grains, legumes, nuts, avocados, and olive oil. Follow-up laboratory results at two months demonstrated TC increased to 317 mg/dL and LDL-C to 203 mg/dL (see Figure).</div><div>The atypical response to the MedDiet resulted in further diagnostic testing, which revealed a significantly elevated beta-sitosterol level of 11 mg/L (normal &lt;5 mg/L) highly suggestive of phytosterolemia. HT was prescribed ezetimibe 10 mg, discontinued the MedDiet, and was educated on a low-plant sterol diet. After one month, TC was 193 mg/dL and LDL-C was 106 mg/dL. After 6 months on the treatment plan, TC decreased to 180 mg/dL, LDL-C decreased to 90 mg/dL, and beta-sitosterol decreased to 2.8 mg/L. She was encouraged to continue with the current therapeutic regimen and referred to a registered dietitian to assure optimal nutrition with a low-plant sterol diet</div></div><div><h3>Conclusions</h3><div>Though extremely rare, phytosterolemia should be considered in patients with hypercholesterolemia who have paradoxical responses to whole food, plant-based diets or those with early ASCVD without obvious etiology. In this patient, diagnosis was via laboratory assays that showed elevated plasma plant sterol levels, including beta-sitosterol. Variants of ABCG5 and ABCG8 genes can provide genetic confirmation. Lipid-lowering was achieved with a low-plant sterol diet and ezetimibe 10 mg.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"19 3","pages":"Pages e34-e35"},"PeriodicalIF":3.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phytosterolemia: A case of paradoxical hypercholesterolemia in response to a mediterranean diet\",\"authors\":\"Rahul Rege MD,&nbsp;Carol Kirkpatrick PhD,&nbsp;Alexandria Wolz RD,&nbsp;Eugenia Gianos MD,&nbsp;Saman Suleman BS\",\"doi\":\"10.1016/j.jacl.2025.04.047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background/Synopsis</h3><div>Phytosterolemia is a rare autosomal recessive lipid disorder caused by variants of the sterol efflux transporter genes ABCG5 and ABCG8 leading to increased intestinal absorption and decreased hepatic elimination of plant sterols. Patients may be misdiagnosed with heterozygous familial hypercholesterolemia. Additionally, they may present with atypical responses to nutrition interventions recommended for atherosclerotic cardiovascular disease (ASCVD) prevention.</div></div><div><h3>Objective/Purpose</h3><div>To describe the clinical pathway of a patient who experienced increased total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels after adopting a Mediterranean dietary pattern and outline diagnostic testing and management strategies for a rare lipid disorder.</div></div><div><h3>Methods</h3><div>We present a case report.</div></div><div><h3>Results</h3><div>HT is a 54-year-old post-menopausal woman who presented to preventive cardiology clinic for consultation for hypercholesterolemia. Baseline TC was 256 mg/dL and LDL-C was 148 mg/dL. HT was physically active with no history of smoking. Family history was negative for premature ASCVD. On physical exam, she had a BMI of 22.49 kg/m<sup>2</sup>, a normal cardiovascular exam, and no xanthomas were noted.</div><div>HT's 10-year ASCVD risk score indicated low-risk (1.1%). HT was encouraged to follow the Mediterranean dietary pattern (MedDiet) to address her elevated LDL-C levels. HT demonstrated good adherence and increased her intake of whole grains, legumes, nuts, avocados, and olive oil. Follow-up laboratory results at two months demonstrated TC increased to 317 mg/dL and LDL-C to 203 mg/dL (see Figure).</div><div>The atypical response to the MedDiet resulted in further diagnostic testing, which revealed a significantly elevated beta-sitosterol level of 11 mg/L (normal &lt;5 mg/L) highly suggestive of phytosterolemia. HT was prescribed ezetimibe 10 mg, discontinued the MedDiet, and was educated on a low-plant sterol diet. After one month, TC was 193 mg/dL and LDL-C was 106 mg/dL. After 6 months on the treatment plan, TC decreased to 180 mg/dL, LDL-C decreased to 90 mg/dL, and beta-sitosterol decreased to 2.8 mg/L. She was encouraged to continue with the current therapeutic regimen and referred to a registered dietitian to assure optimal nutrition with a low-plant sterol diet</div></div><div><h3>Conclusions</h3><div>Though extremely rare, phytosterolemia should be considered in patients with hypercholesterolemia who have paradoxical responses to whole food, plant-based diets or those with early ASCVD without obvious etiology. In this patient, diagnosis was via laboratory assays that showed elevated plasma plant sterol levels, including beta-sitosterol. Variants of ABCG5 and ABCG8 genes can provide genetic confirmation. Lipid-lowering was achieved with a low-plant sterol diet and ezetimibe 10 mg.</div></div>\",\"PeriodicalId\":15392,\"journal\":{\"name\":\"Journal of clinical lipidology\",\"volume\":\"19 3\",\"pages\":\"Pages e34-e35\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical lipidology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1933287425001230\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287425001230","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景/简介植物甾醇血症是一种罕见的常染色体隐性脂质疾病,由甾醇外排转运基因ABCG5和ABCG8变异引起,导致肠道吸收增加,肝脏消除植物甾醇减少。患者可能被误诊为杂合子家族性高胆固醇血症。此外,他们可能对推荐用于预防动脉粥样硬化性心血管疾病(ASCVD)的营养干预有非典型反应。目的/目的描述1例采用地中海饮食模式后总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)水平升高的患者的临床途径,概述一种罕见脂质疾病的诊断检测和治疗策略。方法报告1例。结果sht是一名54岁绝经后妇女,因高胆固醇血症到预防心脏病诊所就诊。基线TC为256 mg/dL, LDL-C为148 mg/dL。他身体活跃,没有吸烟史。早发性ASCVD家族史阴性。体检时,患者BMI为22.49 kg/m2,心血管检查正常,未见黄瘤。HT的10年ASCVD风险评分显示为低风险(1.1%)。鼓励HT遵循地中海饮食模式(MedDiet)来解决她升高的LDL-C水平。HT表现出良好的依从性,并增加了全谷物、豆类、坚果、鳄梨和橄榄油的摄入量。随访两个月后的实验室结果显示,TC增加到317 mg/dL, LDL-C增加到203 mg/dL(见图)。对MedDiet的非典型反应导致进一步的诊断测试,结果显示β -谷甾醇水平显著升高,为11 mg/L(正常和5 mg/L),高度提示植物甾醇血症。给他开了10毫克依折替贝,停止了MedDiet,并接受了低植物固醇饮食的教育。1个月后,TC为193 mg/dL, LDL-C为106 mg/dL。治疗6个月后,TC降至180 mg/dL, LDL-C降至90 mg/dL, β -谷甾醇降至2.8 mg/L。她被鼓励继续目前的治疗方案,并咨询了注册营养师,以确保低植物甾醇饮食的最佳营养。结论:尽管极为罕见,但高胆固醇血症患者对全食物、植物性饮食有矛盾反应,或早期ASCVD无明显病因的患者应考虑植物甾醇血症。在该患者中,诊断是通过实验室检测显示血浆植物固醇水平升高,包括-谷甾醇。ABCG5和ABCG8基因的变异可以提供遗传学上的证实。通过低植物固醇饮食和依折麦布10毫克达到降脂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Phytosterolemia: A case of paradoxical hypercholesterolemia in response to a mediterranean diet

Background/Synopsis

Phytosterolemia is a rare autosomal recessive lipid disorder caused by variants of the sterol efflux transporter genes ABCG5 and ABCG8 leading to increased intestinal absorption and decreased hepatic elimination of plant sterols. Patients may be misdiagnosed with heterozygous familial hypercholesterolemia. Additionally, they may present with atypical responses to nutrition interventions recommended for atherosclerotic cardiovascular disease (ASCVD) prevention.

Objective/Purpose

To describe the clinical pathway of a patient who experienced increased total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels after adopting a Mediterranean dietary pattern and outline diagnostic testing and management strategies for a rare lipid disorder.

Methods

We present a case report.

Results

HT is a 54-year-old post-menopausal woman who presented to preventive cardiology clinic for consultation for hypercholesterolemia. Baseline TC was 256 mg/dL and LDL-C was 148 mg/dL. HT was physically active with no history of smoking. Family history was negative for premature ASCVD. On physical exam, she had a BMI of 22.49 kg/m2, a normal cardiovascular exam, and no xanthomas were noted.
HT's 10-year ASCVD risk score indicated low-risk (1.1%). HT was encouraged to follow the Mediterranean dietary pattern (MedDiet) to address her elevated LDL-C levels. HT demonstrated good adherence and increased her intake of whole grains, legumes, nuts, avocados, and olive oil. Follow-up laboratory results at two months demonstrated TC increased to 317 mg/dL and LDL-C to 203 mg/dL (see Figure).
The atypical response to the MedDiet resulted in further diagnostic testing, which revealed a significantly elevated beta-sitosterol level of 11 mg/L (normal <5 mg/L) highly suggestive of phytosterolemia. HT was prescribed ezetimibe 10 mg, discontinued the MedDiet, and was educated on a low-plant sterol diet. After one month, TC was 193 mg/dL and LDL-C was 106 mg/dL. After 6 months on the treatment plan, TC decreased to 180 mg/dL, LDL-C decreased to 90 mg/dL, and beta-sitosterol decreased to 2.8 mg/L. She was encouraged to continue with the current therapeutic regimen and referred to a registered dietitian to assure optimal nutrition with a low-plant sterol diet

Conclusions

Though extremely rare, phytosterolemia should be considered in patients with hypercholesterolemia who have paradoxical responses to whole food, plant-based diets or those with early ASCVD without obvious etiology. In this patient, diagnosis was via laboratory assays that showed elevated plasma plant sterol levels, including beta-sitosterol. Variants of ABCG5 and ABCG8 genes can provide genetic confirmation. Lipid-lowering was achieved with a low-plant sterol diet and ezetimibe 10 mg.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.00
自引率
6.80%
发文量
209
审稿时长
49 days
期刊介绍: Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信